EPHA2[Biotin], His & Avi, Cynomolgus
EPHA2[Biotin], His & Avi, Cynomolgus

The purity of EPHA2[Biotin], His & Avi, Cynomolgus is greater than 95% as determined by SEC-HPLC.

EPHA2[Biotin], His & Avi, Cynomolgus

EPHA2[Biotin], His & Avi, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

EPHA2[Biotin], His & Avi, Cynomolgus

Ephrin type-A receptor 2 (EPHA2) is a receptor tyrosine kinase (RTK), whose over-expression has been observed in a variety of cancers, including breast cancer. EPHA2 expression may be causally related to tumorigenesis; therefore, it is important to understand how EPHA2 gene (EPHA2) expression is regulated.
Z04362
¥123,118.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
EPHA2 (Ala24-Ser534)
Accession # Q1KL86		 His Avi
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 59.2 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • EPHA2[Biotin], His & Avi, Cynomolgus
    • EPHA2[Biotin], His & Avi, Cynomolgus

    The purity of EPHA2[Biotin], His & Avi, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • EPHA2[Biotin], His & Avi, Cynomolgus
    • EPHA2[Biotin], His & Avi, Cynomolgus

    EPHA2[Biotin], His & Avi, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Ephrin type-A receptor 2 (EPHA2) is a receptor tyrosine kinase (RTK), whose over-expression has been observed in a variety of cancers, including breast cancer. EPHA2 expression may be causally related to tumorigenesis; therefore, it is important to understand how EPHA2 gene (EPHA2) expression is regulated.
Synonyms Ephrin type-A receptor 2; EPHA2

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.